Cargando…
MiR-139-5p has an antidepressant-like effect by targeting phosphodiesterase 4D to activate the cAMP/PKA/CREB signaling pathway
BACKGROUND: Phosphodiesterase 4D (PDE4D) inhibitor is commonly used to treat depression, but side effects seriously decrease its efficacy. PDE4D was a downstream target mRNA of miR-139-5p. Therefore, we examined the effects of hippocampal miR-139-5p gain- and loss-of-function on depression-like beha...
Autores principales: | Huang, Peng, Wei, Songren, Luo, Meng, Tang, Zhuohong, Lin, Qingmei, Wang, Xing, Luo, Mi, He, Yanjun, Wang, Chuan, Wei, Dezhan, Xia, Chenglai, Xu, Jiangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576692/ https://www.ncbi.nlm.nih.gov/pubmed/34790800 http://dx.doi.org/10.21037/atm-21-5149 |
Ejemplares similares
-
cAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in rats
por: Liu, Xu, et al.
Publicado: (2016) -
Complex roles of cAMP–PKA–CREB signaling in cancer
por: Zhang, Hongying, et al.
Publicado: (2020) -
The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB
por: Kandel, Eric R
Publicado: (2012) -
cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach
por: Ahmed, Muhammad Bilal, et al.
Publicado: (2022) -
Gap Junction-Mediated Intercellular Communication of cAMP Prevents CDDP-Induced Ototoxicity via cAMP/PKA/CREB Pathway
por: Kim, Yeon Ju, et al.
Publicado: (2021)